Last Updated On 4/12/2023 4:54:18 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
Employment |
No Relationships to Disclose |
|
|
Leadership |
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests |
No Relationships to Disclose |
|
|
Honoraria |
No Relationships to Disclose |
|
|
Consulting or Advisory Role |
Company: Lilly/ImClone |
Recipient: You |
Company: Roche/Genentech |
Recipient: You |
Company: Bristol-Myers Squibb |
Recipient: You |
Company: Merck |
Recipient: You |
Company: Bayer |
Recipient: You |
Company: AstraZeneca |
Recipient: You |
Company: Taiho Pharmaceutical |
Recipient: You |
Company: Astellas Pharma |
Recipient: You |
Company: Macrogenics |
Recipient: You |
Company: Daiichi Sankyo/Astra Zeneca |
Recipient: You |
Company: Amgen |
Recipient: You |
|
Speakers' Bureau |
No Relationships to Disclose |
|
|
Research Funding |
No Relationships to Disclose |
|
|
Patents, Royalties, Other Intellectual Property |
No Relationships to Disclose |
|
|
Expert Testimony |
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses |
No Relationships to Disclose |
|
|
Other Relationship |
No Relationships to Disclose |
|
|
(OPTIONAL) Uncompensated Relationships |
not answered |
|
|
(OPTIONAL) Open Payments Link |
not answered |
|
|